共 50 条
- [21] Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : 998 - 1003
- [23] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIA TRIAL OF A CA2+ CHANNEL α2Δ LIGAND, PD-0299685, FOR THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E335 - E335
- [27] A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome [J]. JOURNAL OF UROLOGY, 2017, 198 (02): : 376 - 382
- [28] Commentary: Efficacy of Clorpactin in refractory bladder pain syndrome/interstitial cystitis: a randomized controlled trial [J]. International Urogynecology Journal, 2021, 32 : 1185 - 1185
- [29] Double-blind randomized placebo-controlled trial of sibutramine [J]. OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
- [30] Intraoperative acupuncture for posttonsillectomy pain: A randomized, double-blind, placebo-controlled trial [J]. LARYNGOSCOPE, 2015, 125 (08): : 1972 - 1978